MedTrace Logo

A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

NCT00947674 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2012-12-06

No results posted yet for this study

Summary

This is a prospective, randomized, double-blind, sham treatment controlled multicenter study.

Conditions

Interventions

DEVICE

Cellsorba EX

conduct treatment twice a week for 3 weeks and once a week for 4 weeks, total 10 times

Sponsors & Collaborators

  • Asahi Kasei Medical Europe GmbH

    collaborator INDUSTRY

  • Asahi Kasei Medical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-01-31
Completion
2012-10-31

Countries

  • Czechia
  • Germany
  • Israel
  • Japan
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947674 on ClinicalTrials.gov